BASF Shares Creep Toward 52-Week Peak as AgChem Spin-Off and Analyst Downgrades Pull in Opposite Directions

BASF shares edge up despite downgrades; AgChem separation advances, IPO targeted for mid-2027. Q2 EBITDA jumps 54%, guidance raised.

The chemicals giant finds itself at an unusual crossroads: its stock is trading within striking distance of a yearly high, yet the analyst community is growing noticeably cooler on the shares. Two separate research houses — MWB among them — trimmed their recommendations on BASF from "Buy" to "Hold" on Wednesday, citing a familiar refrain: the valuation gap to fair value has closed, and a fresh catalyst has yet to emerge. Price targets remain pinned at €55.00.

The market's response was telling. Rather than punishing the stock for the downgrades, BASF shares edged up 1.3% to €53.45, leaving the paper just 2.9% shy of its 52-week high of €55.05. That resilience speaks to the structural supports underpinning the stock — cost savings programs and an ongoing share buyback — even as the free cash flow conversion continues to draw criticism from the sell-side.

MWB framed its decision around a "normalized risk-reward profile," suggesting the asymmetry that once favored upside has flattened after months of strong price appreciation. The implication for investors is straightforward: the tailwind from obvious undervaluation has largely played out, and further gains will now require concrete operational triggers rather than a simple re-rating.

Grid Attack Delays Lausitz Plant Start-Up

Operationally, the picture is more complicated. BASF was forced to postpone the planned commissioning of a facility at its Industriepark Lausitz site in Schwarzheide on Wednesday after an attack on a substation near Jänschwalde disrupted regional power supplies. The site, part of the group's battery materials operations, sits within the 300-hectare industrial park. No new start-up date has been announced.

The delay is an unwelcome wrinkle for a division that forms part of BASF's strategic growth ambitions in the energy transition space, though it appears to be an external disruption rather than a reflection of any internal execution issues.

AgChem Separation Accelerates

Meanwhile, the planned carve-out of BASF's agricultural chemicals division is gathering pace. Board member Livio Tedeschi confirmed last Wednesday that the separation of the business in North and South America and Europe is now largely complete, with Asia expected to follow by year-end.

The company is simultaneously establishing a dedicated headquarters for the future standalone entity, targeting mid-2027 as the point when all conditions for an initial public offering will be in place. Financial circles, citing Handelsblatt, estimate the division could be valued at between €20 billion and €30 billion — roughly half of BASF's entire current market capitalization.

The move fits a broader pattern of portfolio reshaping. Earlier this summer, BASF sold its Coatings business to private equity firm Carlyle, booking a post-tax divestment gain of €3.5 billion alongside roughly €5.8 billion in cash proceeds. These transactions underscore a deliberate strategy of shedding peripheral assets to concentrate on core segments.

Turnaround Momentum Backs the Strategy

The separation plans arrive at a moment when BASF's underlying operations are showing genuine momentum. Late July brought news of a 54% year-on-year jump in second-quarter EBITDA before special items, fueled by higher volumes, improved pricing, and accelerated cost reductions. Management responded by lifting its full-year EBITDA guidance to a range of €6.9 billion to €7.7 billion, up from a previous €6.2 billion to €7.0 billion — a revision that has supported the share price in recent weeks.

The cost discipline is evident in the numbers: roughly 7,000 positions have been eliminated since the start of 2024, with annual savings now running at €2.0 billion and on track to hit the year-end target of €2.3 billion. The weak spot remains free cash flow, which came in at minus €1.6 billion for the first half and minus €189 million for the second quarter alone, weighed down by working capital effects and restructuring charges.

People, Products, and Pipeline

On the human capital front, BASF kicked off training programs at its Ludwigshafen site with 360 new entrants — 322 apprentices, 38 participants in the "Start in den Beruf" program, and 59 career changers. Labor Director Katja Scharpwinkel stressed the importance of investing in skilled workers, noting that more than 10,000 applications were received for the current year, roughly 2,000 more than the previous year. Applications for the 2027 training cycle are already open.

Innovation continues in the consumer goods segment, where BASF received the Ringier Technology Innovation Award in the surfactants category in Shanghai for its Plantapon Amino ASP cleansing technology — a vegan, RSPO-certified amino acid formulation free of preservatives, used in facial cleansers and shampoos. In agriculture, the company launched new fungicides for viticulture and introduced Apthena, a pheromone-based spray offering a biological alternative for aphid control, which field trials showed significantly boosted beneficial insect populations in peas and sugar beets.

A Stock Between Two Forces

The shares closed Tuesday at €52.76, up 19% year-to-date and 4.2% below the April peak. Shareholders also approved a dividend of €2.25 per share for fiscal 2025 at the annual meeting in late April, signaling that payout policy remains intact despite the ongoing restructuring.

For now, BASF presents a study in contrasts: analysts see limited near-term upside from valuation alone, while the market continues to reward the combination of operational recovery, portfolio simplification, and the prospect of an AgChem IPO that could unlock significant value. The next leg higher, many observers suggest, will depend on details of the spin-off's capital structure and free float — and on whether the company can convert its operational improvements into the free cash flow that has so far proven elusive.